Comparison of pathological findings between patients with relapsed and non-relapsed immunoglobin G4-related disease
Open Access
- 9 September 2021
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Chinese Medical Journal
- Vol. 135 (4), 465-467
- https://doi.org/10.1097/cm9.0000000000001713
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 4 references indexed in Scilit:
- The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related DiseaseArthritis & Rheumatology, 2019
- Clinical outcomes and predictive relapse factors of IgG4‐related disease following treatment: a long‐term cohort studyJournal of Internal Medicine, 2019
- Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trialRheumatology, 2018
- Consensus statement on the pathology of IgG4-related diseaseLaboratory Investigation, 2012